Henry Geoffrey McMillan
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Frank Hall | M | 63 |
IS Pharma Plc
IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | 2 Jahre |
Nigel Goldsmith | M | 62 |
IS Pharma Plc
IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | - |
Michael McDonald | M | - |
IS Pharma Plc
IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | 3 Jahre |
Peter J. Murray | M | 66 |
IS Pharma Plc
IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Henry Geoffrey McMillan
- Persönliches Netzwerk